3151 Stock Overview
Engages in the wholesale and retail sale of pharmaceutical products in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Vital KSK Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,245.00 |
| 52 Week High | JP¥1,439.00 |
| 52 Week Low | JP¥1,002.00 |
| Beta | 0.046 |
| 11 Month Change | -5.61% |
| 3 Month Change | 11.46% |
| 1 Year Change | 15.71% |
| 33 Year Change | 58.40% |
| 5 Year Change | 14.12% |
| Change since IPO | 123.12% |
Recent News & Updates
Shareholder Returns
| 3151 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | -2.5% | -0.4% | 1.1% |
| 1Y | 15.7% | -2.6% | 12.3% |
Return vs Industry: 3151 exceeded the JP Healthcare industry which returned -2.6% over the past year.
Return vs Market: 3151 exceeded the JP Market which returned 12.3% over the past year.
Price Volatility
| 3151 volatility | |
|---|---|
| 3151 Average Weekly Movement | 4.2% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in JP Market | 10.1% |
| 10% least volatile stocks in JP Market | 3.4% |
Stable Share Price: 3151 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 3151's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 3,705 | Taisuke Murai | www.vitalksk.co.jp |
Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company is involved in the nursing care, agrochemical wholesale, and veterinary drug wholesale business. It also engages in the medical and pharmacy consulting business.
Vital KSK Holdings, Inc. Fundamentals Summary
| 3151 fundamental statistics | |
|---|---|
| Market cap | JP¥61.26b |
| Earnings (TTM) | JP¥5.92b |
| Revenue (TTM) | JP¥590.35b |
10.4x
P/E Ratio0.1x
P/S RatioIs 3151 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3151 income statement (TTM) | |
|---|---|
| Revenue | JP¥590.35b |
| Cost of Revenue | JP¥541.82b |
| Gross Profit | JP¥48.53b |
| Other Expenses | JP¥42.61b |
| Earnings | JP¥5.92b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 120.23 |
| Gross Margin | 8.22% |
| Net Profit Margin | 1.00% |
| Debt/Equity Ratio | 6.6% |
How did 3151 perform over the long term?
See historical performance and comparisonDividends
3.5%
Current Dividend Yield19%
Payout RatioDoes 3151 pay a reliable dividends?
See 3151 dividend history and benchmarks| Vital KSK Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 03 2024 |
| Days until Ex dividend | 38 days |
| Days until Dividend pay date | 29 days |
Does 3151 pay a reliable dividends?
See 3151 dividend history and benchmarks